Pocketpair, the developer behind Palworld, has definitively ruled out transitioning the game to a free-to-play (F2P) or games-as-a-service (GaaS) model. This follows recent reports suggesting the developer was exploring such options.
Palworld Remains Buy-to-Play
Future Plans: DLC and Skins Under Consideration
In a recent statement on Twitter (X), the Palworld team clarified their position: "Regarding the Future of Palworld TL;DR – We are not changing our game’s business model, it will remain buy-to-play and not f2p or GaaS." This announcement addresses earlier reports stemming from an interview where Pocketpair discussed various potential future directions for the game. The team explained that while they considered various options to ensure Palworld's long-term growth, the F2P/GaaS model ultimately wasn't deemed suitable. They emphasized that Palworld was not originally designed for such a model, and adapting it would be too extensive. Furthermore, they acknowledged player preference, stating that they always prioritize their players' wishes. The statement concluded with an apology for any concern caused by previous reports and a thank you for continued support.
The developer reassured fans of their commitment to making Palworld the best possible game. They also clarified that a previously published interview with ASCII Japan, which sparked the initial reports, was conducted several months ago. While that interview mentioned plans for new content, including Pals and raid bosses, the current statement focuses on a different path forward. Pocketpair is now exploring the possibility of releasing skins and DLC as a means of supporting ongoing development, promising further discussion on this topic as plans solidify.
Separately, a potential PS5 version of Palworld has been listed in announcements for the upcoming Tokyo Game Show 2024 (TGS 2024). However, as noted by Gematsu, this list, published by the Computer Entertainment Supplier’s Association (CESA), shouldn't be considered definitive confirmation of an announcement.